Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
DNA and RNA binding by the Wilms' tumour gene 1 (WT1) protein +KTS and -KTS isoforms-From initial observations to recent global genomic analyses.
|
29240258 |
2018 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
|
27612989 |
2017 |
Nephroblastoma
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
(1) KTS mutations cause isolated NS with absence of WT in 46,XX females.
|
20595692 |
2010 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Three types of WT1 messages (total, exon 5(+) and KTS(+)) and WT1 immunostaining of these diseases were analyzed.
|
17803653 |
2007 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
|
16630117 |
2006 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
This induction was EWS-WT1(-KTS)-specific, and more importantly, TALLA-1 protein was expressed in the three independent cases of DSRCT.
|
14633590 |
2003 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
WT1 transcript analysis showed reversal of the normal positive/negative KTS (lysine, threonine, and serine) isoform ratio, confirming the diagnosis of FS.
|
12050205 |
2002 |
Nephroblastoma
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
In this study, two +KTS deletion mutants of WT1 were made as well as a WT1 mutant mimicking a mutation found in a patient who had diffuse mesangial sclerosis, end stage renal failure and Wilms tumor.
|
10586431 |
1999 |
Nephroblastoma
|
0.090 |
Biomarker
|
disease |
BEFREE |
Here, we show that WT1 -KTS isoforms associate and synergize with SF-1 to promote MIS expression.
|
9590178 |
1998 |
Frasier Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
(2) KTS mutations cause Frasier syndrome with gonadoblastoma risk in 46,XY phenotypic females.
|
20595692 |
2010 |
Frasier Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Here we show that a decrease in WT1 + KTS isoforms due to disruption of alternative splicing of the WT1 gene in a FS patient is associated with diminished expression of the transcription factors SRY and SOX9 in Sertoli cells.
|
18271004 |
2008 |
Frasier Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
Germline intronic mutations leading to the loss of the +KTS isoforms have been observed in all patients with Frasier syndrome.
|
16927106 |
2006 |
Frasier Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
WT1 transcript analysis showed reversal of the normal positive/negative KTS (lysine, threonine, and serine) isoform ratio, confirming the diagnosis of FS.
|
12050205 |
2002 |
Frasier Syndrome
|
0.080 |
AlteredExpression
|
disease |
BEFREE |
From these results, we suggest that the alteration of +KTS WT1 expression be responsible for the rapid progression of renal diseases in DDS and FS.
|
10586431 |
1999 |
Frasier Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
KTS (lysine-threonine-serine) splice site mutations in WT1 intron 9 have been described in patients with Frasier syndrome, another rare syndrome defined by focal and segmental glomerulosclerosis (FSGS), XY pseudohermaphroditism, and frequent occurrence of gonadoblastoma.
|
10505700 |
1999 |
Frasier Syndrome
|
0.080 |
GeneticVariation
|
disease |
BEFREE |
Exon 9 mutations in the WT1 gene, without influencing KTS splice isoforms, are also responsible for Frasier syndrome.
|
10571943 |
1999 |
Frasier Syndrome
|
0.080 |
Biomarker
|
disease |
BEFREE |
Frasier syndrome is caused by defective alternative splicing of WT1 leading to an altered ratio of WT1 +/-KTS splice isoforms.
|
9499425 |
1998 |
Childhood Kidney Wilms Tumor
|
0.040 |
Biomarker
|
disease |
BEFREE |
Distinct global binding patterns of the Wilms tumor gene 1 (WT1) -KTS and +KTS isoforms in leukemic cells.
|
27612989 |
2017 |
Childhood Kidney Wilms Tumor
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
(1) KTS mutations cause isolated NS with absence of WT in 46,XX females.
|
20595692 |
2010 |
Childhood Kidney Wilms Tumor
|
0.040 |
Biomarker
|
disease |
BEFREE |
Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro.
|
16630117 |
2006 |
Childhood Kidney Wilms Tumor
|
0.040 |
GeneticVariation
|
disease |
BEFREE |
In this study, two +KTS deletion mutants of WT1 were made as well as a WT1 mutant mimicking a mutation found in a patient who had diffuse mesangial sclerosis, end stage renal failure and Wilms tumor.
|
10586431 |
1999 |
Gonadoblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
(2) KTS mutations cause Frasier syndrome with gonadoblastoma risk in 46,XY phenotypic females.
|
20595692 |
2010 |
Gonadoblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Frasier syndrome is characterized by a 46 XY disorder of sex development, nephropathy, and increased risk for gonadoblastoma due to Wilms tumor 1(WT1) mutation in the donor splice site of intron-9, resulting in the splice form +KTS.
|
19653292 |
2009 |
Gonadoblastoma
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
KTS (lysine-threonine-serine) splice site mutations in WT1 intron 9 have been described in patients with Frasier syndrome, another rare syndrome defined by focal and segmental glomerulosclerosis (FSGS), XY pseudohermaphroditism, and frequent occurrence of gonadoblastoma.
|
10505700 |
1999 |
Nephrotic Syndrome
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Nine (82 %) patients with missense mutations presented with congenital/infantile nephrotic syndrome, while 8 (80 %) with KTS splicing mutations presented with childhood-onset SRNS.
|
27300205 |
2017 |